Tranxene and Thinking abnormal - a phase IV clinical study of FDA data

Summary:

Thinking abnormal is reported as a side effect among people who take Tranxene (clorazepate dipotassium), especially for people who are female, 60+ old, also take Lamictal, and have Hypopituitarism.

The phase IV clinical study analyzes which people have Thinking abnormal when taking Tranxene. It is created by eHealthMe based on reports of 6,399 people who have side effects when taking Tranxene from the FDA, and is updated regularly.

What is Tranxene?

Tranxene has active ingredients of clorazepate dipotassium. It is often used in stress and anxiety. eHealthMe is studying from 6,550 Tranxene users. Check the latest studies of Tranxene.

What is Thinking abnormal?

Thinking abnormal is found to be associated with 1,060 drugs and 1,185 conditions by eHealthMe. Check the latest studies of Thinking abnormal.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

6,399 people reported to have side effects when taking Tranxene.
Among them, 11 people (0.17%) have Thinking abnormal.

Among these 11 people:

What is the gender of people who have Thinking abnormal when taking Tranxene? *

female: 81.82 %
male: 18.18 %

What is the age of people who have Thinking abnormal when taking Tranxene? *

What are other drugs people take besides Tranxene? *

What are other side effects people have besides Thinking abnormal? *

Dizziness: 4 people, 36.36%
Drowsiness: 4 people, 36.36%
Memory Loss: 4 people, 36.36%
Pain In Extremity: 3 people, 27.27%
Nausea (feeling of having an urge to vomit): 3 people, 27.27%
Confusion: 3 people, 27.27%
Snoring: 3 people, 27.27%
Hypoaesthesia (reduced sense of touch or sensation): 3 people, 27.27%
Flatulence (flatus expelled through the anus): 3 people, 27.27%
Fall: 3 people, 27.27%

What are the existing conditions these people have? *

Hypopituitarism (diminished hormone secretion by the pituitary gland, causing dwarfism in children and premature aging in adults): 2 people, 18.18%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 9.09%
Migraine (headache): 1 person, 9.09%
Laxative Supportive Care: 1 person, 9.09%
Irritable Bowel Syndrome: 1 person, 9.09%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 9.09%
High Blood Cholesterol: 1 person, 9.09%
Depression: 1 person, 9.09%
Complex Partial Seizures (epileptic seizure): 1 person, 9.09%
Cardiac Disorder: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Tranxene and have Thinking abnormal?

- Check whether Thinking abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tranxene:

Tranxene (6,550 reports)

Browse all side effects of Tranxene:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Thinking abnormal:

Thinking abnormal (1,060 drugs)

Browse all the conditions that are associated with Thinking abnormal:

Thinking abnormal (1,185 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on clorazepate dipotassium (the active ingredients of Tranxene) and Tranxene (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.